DrugPatentWatch Database Preview

Ariad Company Profile

« Back to Dashboard

What is the competitive landscape for ARIAD, and when can generic versions of ARIAD drugs launch?

ARIAD has two approved drugs.

There are six US patents protecting ARIAD drugs.

There are eighty-seven patent family members on ARIAD drugs in twenty-one countries and fourteen supplementary protection certificates in twelve countries.

Summary for Ariad

International Patents:	87
US Patents:	6
Tradenames:	2
Ingredients:	2
NDAs:	2
Patent Litigation for Ariad:	See patent lawsuits for Ariad

Drugs and US Patents for Ariad

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ariad	ICLUSIG	ponatinib hydrochloride	TABLET;ORAL	203469-001	Dec 14, 2012		RX	Yes	No	9,029,533
Ariad	ICLUSIG	ponatinib hydrochloride	TABLET;ORAL	203469-003	Apr 23, 2015		RX	Yes	No	9,029,533
Ariad	ALUNBRIG	brigatinib	TABLET;ORAL	208772-003	Oct 2, 2017		RX	Yes	Yes	9,611,283
Ariad	ALUNBRIG	brigatinib	TABLET;ORAL	208772-002	Apr 28, 2017		RX	Yes	No

International Patents for Ariad Drugs

Country	Document Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2009143389
Canada	2815506
China	101489558
Denmark	2300013

Supplementary Protection Certificates for Ariad Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2013027,C1973545	Lithuania		PRODUCT NAME: PONATINIBUM; REGISTRATION NO/DATE: EU/1/13/839/001, 2013 07 03 EU/1/13/839/002, 2013 07 03 EU/1/13/839/003, 2013 07 03 EU/1/13/839/004 20130703
1973545/01	Switzerland		PRODUCT NAME: PONATINIBUM; REGISTRATION NO/DATE: SWISSMEDIC 63097 12.02.2014
00631	Netherlands		PRODUCT NAME: PONATINIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, SOLVAAT OF HYDRAAT; REGISTRATION NO/DATE: EU/1/13/839/001-004 20130701
0	Finland

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Ariad